Edwards Lifesciences
Builds catheter-based and surgical heart-valve systems led by the SAPIEN TAVR platform.
$91.14
After-hours close+0.94 (+1.04%)
At close$90.20(+0.28%)
Something off on this page? Send us feedback.
Breakdown13F · Form 4
Institutions 105.28%Insiders 0.15%
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 575.80M · Float 568.38M · 98.7% free float
Institutions13F, as of Jun 30, 2026
1,368 holders · 606.19M shares · 167 new positions · 634 increased · 470 reduced · 126 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 58.79M | 10.21% | +6.20M | Aug 7, 2026 |
| Vanguard Capital Management LLC | 37.62M | 6.53% | −111.8K | Aug 13, 2026 |
| Vanguard Portfolio Management LLC | 26.41M | 4.59% | +4.4K | Aug 13, 2026 |
| State Street Corp | 26.32M | 4.57% | +25.5K | Aug 7, 2026 |
| JPMorgan Chase & Co | 22.78M | 3.96% | +1.04M | Aug 12, 2026 |
| Wellington Management Group LLP | 16.83M | 2.92% | −5.18M | Aug 14, 2026 |
| Geode Capital Management, LLC | 15.44M | 2.68% | +2.30M | Aug 12, 2026 |
| Bank of New York Mellon Corp | 14.08M | 2.45% | −2.65M | Aug 6, 2026 |
Beneficial owners13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Vanguard Capital Management | 7.54% | 43.48M | 13G | Apr 29, 2026 ↗ |
| BlackRock, Inc. | 7.50% | 44.27M | 13G | Oct 17, 2025 ↗ |
| Wellington Group Holdings LLPincl. Wellington Management Group LLP, Wellington Investment Advisors Holdings LLP | 5.23% | 31.53M | 13G | Nov 8, 2024 ↗ |
InsidersForm 4
| Insider | Role | Shares | % outstanding | Filed |
|---|---|---|---|---|
| Larry L. Wood | officer: Global President TAVR & Surg | 206.9K | 0.04% | Aug 18, 2025 |
| Donald E. Jr Bobo | officer: CVP,Strategy/Corp Development | 121.4K | 0.02% | May 27, 2026 |
| Bernard J. Zovighian | director, officer: CEO | 107.8K | 0.02% | Jul 27, 2026 |
| Theodora Mistras | officer: CVP, Chief Financial Officer | 87.6K | 0.02% | Jul 10, 2026 |
| Nicholas J. Valeriani | director | 84.4K | 0.01% | May 8, 2026 |
| Scott B. Ullem | officer: CVP, Chief Financial Officer | 46.7K | 0.01% | May 11, 2026 |
| Daveen Chopra | officer: CVP, TMTT, Surgical & IHFM | 44.3K | 0.01% | Aug 26, 2026 |
| Daniel J. Lippis | officer: CVP, TAVR | 40.0K | 0.01% | Aug 11, 2026 |
| Heisz Leslie Stone | director | 34.2K | 0.01% | May 8, 2026 |
| Wayne Markowitz | officer: CVP, JAPAC | 20.3K | 0.00% | Aug 26, 2026 |
1 ten-percent owner holds 120.15M shares by Form 4, outside the officers-and-directors figure above · 28 people have not refiled in the last 18 months (5.67M shares), so they are not in the figure above
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Aug 28, 2026 | Annette Brulsofficer: CVP, EMEACLA | Sale | 2,644 | $89.98 | 17,984 |
| Aug 26, 2026 | Daveen Chopraofficer: CVP, TMTT, Surgical & IHFM | Sale · 2 lots | 31,800 | $91.02 | 44,324 |
| Aug 26, 2026 | Wayne Markowitzofficer: CVP, JAPAC | Sale | 1,240 | $91.47 | 20,294 |
| Aug 11, 2026 | Daniel J. Lippisofficer: CVP, TAVR | Sale | 619 | $92.03 | 40,034 |
| Jul 30, 2026 | Wayne Markowitzofficer: CVP, JAPAC | Sale | 146 | $86.03 | 21,534 |
| Jul 28, 2026 | Wayne Markowitzofficer: CVP, JAPAC | Sale | 9,628 | $85.06 | 21,680 |
| Jul 27, 2026 | Bernard J. Zovighiandirector, officer: CEO | Sale | 2,921 | $83.93 | 8,916 |
| Jul 10, 2026 | Daniel J. Lippisofficer: CVP, TAVR | Sale | 619 | $91.70 | 40,034 |
| Jun 30, 2026 | Daniel J. Lippisofficer: CVP, TAVR | Sale | 619 | $91.40 | 40,411 |
| Jun 17, 2026 | Bernard J. Zovighiandirector, officer: CEO | Sale | 523 | $87.92 | 11,517 |
CongressHouse and Senate disclosures
| Member | Type | Amount | Owner | Traded | Disclosed |
|---|---|---|---|---|---|
| Rep. Ro Khanna · CA17 | Purchase | $1,001 – $15,000 | May 1, 2026 | Jun 11, 2026 ↗ |